DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Diéras V, Limentani S, Romieu G, Tubiana-Hulin M, Lortholary A, Kaufman P. et al.
Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy.
Ann Oncol 2008;
19: 1255-60
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.